2 suspended. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Suspended 2 |
| Phase 1 | 1 | Suspended 1 |
Follow Atorvastatin: new trials by email Literature Review of Atorvastatin trials Research Report on Atorvastatin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Human Umbilical Cord Mesenchymal Stem Cell Therapy (19#iSCLife®-CI) for Cerebral Infarction Patients in Convalescent Period. Allogeneic umbilical cord mesenchymal stem cell, Aspirin Enteric-coated Tablets & Atorvastatin Calcium - Cerebral Infarction | Phase 1 / Phase 2 | Suspended | Sclnow Biotechnology Co., Ltd. | 40 | 2026-12-31 | 2026-04-23 |
| Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Atorvastatin, Placebo - Nasopharyngeal Carcinoma, Radiation Therapy Complication | Phase 2 | Suspended | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 324 | 2017-01-01 | 2017-12-04 |
Carotid Stenosis (1) · Cerebral Infarction (1) · Nasopharyngeal Carcinoma (1)
Sclnow Biotechnology Co., Ltd. (1) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (1)
China (2)
Lei Guo, Dr (1) · Ying Peng, Ph.D (1)